Skip to main content
Clinical Trials/NCT02694120
NCT02694120
Unknown
Not Applicable

Study on Complications, EfficAcy and Costs of Large Polypectomy

Valduce Hospital0 sites1,000 target enrollmentFebruary 2016
ConditionsPolypectomy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polypectomy
Sponsor
Valduce Hospital
Enrollment
1000
Primary Endpoint
complications of large polypectomy
Last Updated
10 years ago

Overview

Brief Summary

Colonoscopy has been shown to reduce the incidence and mortality of colorectal cancer, through the recognition and removal of pre-cancerous lesions, which in most cases evolve with a sequence that goes through formation of high-grade dysplasia (HGD).

The probability of HGD increases with the increase of the lesion of the polyp itself. Lesions> 2 cm are present in 1% of colonoscopy screening. The resection of these lesions presents a greater technical difficulty and consequently a decrease in the efficiency. The rate of incomplete resection reported in the literature reaches 10% while that of recurrence / residual adenoma 16.4 / 31.7%.

The aim of the study SCALP is to evaluate the incidence of complications, efficacy and cost of endoscopic resection of colic lesions> 2cm in a setting of clinical practice in an unselected population

Registry
clinicaltrials.gov
Start Date
February 2016
End Date
July 2016
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Valduce Hospital
Responsible Party
Principal Investigator
Principal Investigator

Arnaldo Amato

MD

Valduce Hospital

Eligibility Criteria

Inclusion Criteria

  • adult patients undergoing large endoscopic polypectomy

Exclusion Criteria

  • pregnancy
  • incapacity to give informed consent

Outcomes

Primary Outcomes

complications of large polypectomy

Time Frame: 15 days

incidence of polypectomy-related adverse events

Secondary Outcomes

  • costs of large polypectomy(15 days)
  • efficacy of large polypectomy(6 months)

Similar Trials